A Real-world Evidence on Effectiveness and Safety of Blinatumomab in Patients With B-cell Acute Lymphoblastic Leukaemia

Study identification

• EU PAS number:
  EUPAS106021
• Study ID:
  106022
• Official title and acronym:
  A Real-world Evidence on Effectiveness and Safety of Blinatumomab in Patients With B-cell Acute Lymphoblastic Leukaemia
• DARWIN EU® study:
  No
• Study countries:
  China
• Study description:
  No information provided.
• Study status:
  Finalised

Research institutions and networks

No information provided.

Study timelines

Date when funding contract was signed

Planned:01/01/2021

Actual:01/01/2021

Study start date

Planned:01/01/2021

Actual:01/01/2021

Data analysis start date

Planned:31/03/2023

Actual:31/03/2023

Date of final study report

Planned:30/06/2023

Actual:30/06/2023

Sources of funding

Other

More details on funding

The first affliated hospital of soochow university

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable